Effect of fenofibrate in 1113 patients at low-density lipoprotein cholesterol goal but high triglyceride levels: Real-world results and factors associated with triglyceride reduction.
Fibrates are used in patients with dyslipidemia and high cardiovascular risk. However, information regarding drug response to fibrate has been highly limited. We investigated treatment results and factors associated with triglyceride reduction after fenofibrate therapy using large-scale real-world d...
Main Authors: | Yeongmin Woo, Jeong-Soo Shin, Chi-Young Shim, Jung-Sun Kim, Byeong-Keuk Kim, Sungha Park, Hyuk-Jae Chang, Geu-Ru Hong, Young-Guk Ko, Seok-Min Kang, Donghoon Choi, Jong-Won Ha, Myeong-Ki Hong, Yangsoo Jang, Sang-Hak Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC6171908?pdf=render |
Similar Items
-
Triglyceride and Triglyceride-Rich Lipoproteins in Atherosclerosis
by: Bai-Hui Zhang, et al.
Published: (2022-05-01) -
Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk
by: Francesco Baratta, et al.
Published: (2023-02-01) -
The major pathways of lipids (triglyceride and cholesterol) and lipoprotein metabolism
by: Karzan Jalal Salih
Published: (2021-08-01) -
Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol
by: Geevar Zachariah
Published: (2024-03-01) -
Triglycerides and high-density lipoprotein cholesterol are associated with insulinemia in adolescents
by: Ramírez-López Guadalupe, et al.
Published: (2006-01-01)